​Inotiv discloses FCPA probe into primate importation practices


Inotiv disclosed the Securities and Exchange Commission (SEC) is investigating potential violations of the Foreign Corrupt Practices Act (FCPA) by the pharmaceutical testing company regarding its importation of nonhuman primates (NHPs) from Asia.

In May, the SEC requested documents and information from Inotiv and two of its subsidiaries—Envigo Global Services and Orient BioResource Center—for the period beginning Dec. 1, 2017, to present, Inotiv revealed in a regulatory filing Friday.

The company said it is cooperating with the probe.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.